IP Library › Patent Application 16047424
Patent Application
App. No. 16/047,424

CONTROLLED DOSING OF CLOPIDOGREL WITH GASTRIC ACID INHIBITION THERAPIES

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
16/047,424
Abstract

The present invention provides for novel formulations of clopidogrel in combination ton pump inhibitors (PPI), optionally with NSAIDs, for use as improved antiplatelet therapies in stroke and cardiovascular indications.

Claims (5)

1 - 64 . (canceled)

65 . A method of treating a subject with an antiplatelet therapy comprising administering to said subject:

(a) enteric-coated aspirin coformulated with immediate-release omeprazole; and

(b) clopidogrel,

wherein (a) and (b) are dosed at least 10 hours apart.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 12, 2018
From: PLACHETKA, JOHN R.
To: POZEN INC.
Reel/Frame 047478/0480 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 12, 2018
From: POZEN, INC.
To: GENUS LIFESCIENCES, INC.
Reel/Frame 047478/0487 →